You just read:

ASH 2016: Janssen to Present 43 Abstracts with Data on Ibrutinib, Daratumumab and Other Compounds Showing Treatment Advances in Malignant and Non-Malignant Hematologic Conditions

News provided by

Janssen Research & Development, LLC

Nov 03, 2016, 09:59 ET